[1]
“ROLE OF COMORBIDITIES IN OPTIMIZING DECISION-MAKING FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION”, Mediterr J Hematol Infect Dis, vol. 2, no. 2, p. e2010015, Jun. 2010, doi: 10.4084/mjhid.2010.015.